Global Gastroesophageal Reflux Disease Market, By Drug Class (Antacids, Proton Pump Inhibitors, H2 Receptor Blocker, Pro-Kinetic Agents, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028.
Market Analysis and Insights : Global Gastroesophageal Reflux Disease Market
Gastroesophageal reflux disease market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to grow at a CAGR of 2.85% in the above-mentioned forecast period. Rise in the cases of GERD drives the gastroesophageal reflux disease market.
Gastroesophageal reflux disease (GERD) is defined as a type of condition which causes the burning sensation known as heartburn. It occurs when the hydrochloric acid-containing contents of the stomach is travel back up into the lower part of the esophagus and this backward movement is called reflux which causes burning sensation.
Rise in the number of companies worldwide increasingly being subjected to price scrutiny is the vital factor escalating the market growth, also rise in the shift in government focus on promoting consumer accessibility, increase in the demand of medical devices have led various companies to focus on new product developments and innovations, rise in the cases of heartburn and rise in research and development activities conducted by many pharmaceuticals companies are the major factors among others driving the gastroesophageal reflux disease market. Moreover, rise in the technological advancements and modernization in the healthcare devices and increase in the demand from emerging economies will further create new opportunities for gastroesophageal reflux disease market in the forecasted period of 2021-2028.
However, product recalls coupled with shortage of drugs are the major factors among others which will obstruct the market growth, and will further challenge the growth of gastroesophageal reflux disease market in the forecast period mentioned above.
Gastroesophageal reflux disease market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on gastroesophageal reflux disease market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Gastroesophageal Reflux Disease Market Scope and Market Size
Gastroesophageal reflux disease market is segmented on the basis of drug class, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of drug class, gastroesophageal reflux disease market is segmented into antacids, proton pump inhibitors, H2 receptor blocker, pro-kinetic agents and others.
- Based on route of administration, the gastroesophageal reflux disease market is segmented into oral, parenteral and others.
- Based on end-users, the gastroesophageal reflux disease market is segmented into hospitals, homecare, specialty clinics and others.
- The gastroesophageal reflux disease market is also segmented on the basis of distribution channel into hospital pharmacy, online pharmacy and retail pharmacy.
Gastroesophageal Reflux Disease Market Country Level Analysis
Gastroesophageal reflux disease market is analysed and market size insights and trends are provided by country, drug class, route of administration, end-users and distribution channel as referenced above.
The countries covered in the gastroesophageal reflux disease market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the gastroesophageal reflux disease market due to rise in the shift in government focus on promoting consumer accessibility and increase in the demand of medical devices in this region. Asia-Pacific is the expected region in terms of growth in gastroesophageal reflux disease market due to rise in the geriatric population and lifestyle and dietary risk factors such as obesity & high fat diet in this region.
The country section of the gastroesophageal reflux disease market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
Gastroesophageal reflux disease market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for gastroesophageal reflux disease market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the gastroesophageal reflux disease market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Gastroesophageal Reflux Disease Market Share Analysis
Gastroesophageal reflux disease market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to gastroesophageal reflux disease market.
The major players covered in the gastroesophageal reflux disease market report are AstraZeneca, Eisai Co., Ltd, GlaxoSmithKline plc; Takeda Pharmaceutical Company Limited, Johnson & Johnson Services Inc, Mylan N.V., Aurobindo Pharma, Cipla Inc, Zydus Cadila, Amneal Pharmaceuticals LLC, Sun Pharmaceuticals Industries Ltd and Lannett among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-